Comparative Analysis of the Effects of Moringa Oleifera Leaf Extract and Ciprofloxacin On Ocular Bacteria Infection in Owerri, Imo State

References

[1] Centre for Disease Control and Prevention, “Conjunctivitis (Pink Eye),” Atlanta, CDC, 2023.

[2] A. Al-Mansoori and M. Arshad, “Antimicrobial resistance in ocular pathogens,” J. Med. Plants Res., vol. 15, no. 1, pp. 10–17, 2021.

[3] J. W. Fahey, “Moringa oleifera: A review of the medical evidence for its nutritional, therapeutic, and prophylactic properties,” Trees Life J., vol. 1, p. 5, 2005.

[4] P. Siddhuraju and K. Becker, “Antioxidant properties of various solvent extracts of total phenolic constituents from Moringa oleifera leaves,” J. Agric. Food Chem., vol. 51, pp. 2144–2150, 2003.

[5] M. A. Abdalla et al., “Antibacterial activity of Moringa oleifera leaf extracts against selected pathogens,” J. Med. Plants Res., 2022.

[6] A. Abubakar and M. Usman, “Phytochemical screening and antibacterial activity of Moringa oleifera leaf extracts,” Bayero J. Pure Appl. Sci., 2016.

[7] J. B. Harborne, Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis, 3rd ed. London: Chapman & Hall, 1998.

[8] D. E. Okwu, “Phytochemicals and vitamin content of indigenous spices of South Eastern Nigeria,” J. Sustain. Agric. Environ., 2004.

[9] Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing, CLSI M100, 33rd ed., 2023.

[10] I. Matic et al., “Broad-spectrum antibacterial activity of Moringa oleifera,” J. Ethnopharmacol., 2018.

[11] K. A. Colby et al., “Susceptibility patterns of ocular bacterial isolates to ciprofloxacin,” Am. J. Ophthalmol., 2018.

[12] O. Awodele et al., “Toxicological evaluation of the aqueous leaf extract of Moringa oleifera Lam. (Moringaceae),” J. Ethnopharmacol., vol. 139, no. 2, pp. 330–336, 2012.

[13] G. A. Asare et al., “Toxicity potentials of the nutraceutical Moringa oleifera at supra-supplementation levels,” J. Ethnopharmacol., vol. 139, no. 2, pp. 330–336, 2012.

[14] A. A. Oyagbemi et al., “Toxicological evaluation of methanolic extract of Moringa oleifera leaves in liver and kidney of male Wistar rats,” J. Basic Clin. Physiol. Pharmacol., vol. 24, pp. 307–312, 2013.

[15] J. G. Onsare et al., “Screening for antimicrobial activity of Moringa oleifera,” Acad. J. Med. Plants, 2017.

[16] E. M. Uzoegbu, “Effects of Moringa oleifera on intraocular pressure in humans,” J. Basic Clin. Physiol. Pharmacol., 2015.

[17] C. Gopalan, B. V. Rama Sastri, and S. C. Balasubramanian, Nutritive Value of Indian Foods. Hyderabad: National Institute of Nutrition, 1989.

[18] F. Anwar and U. Rashid, “Physico-chemical characteristics of Moringa oleifera seeds and seed oil from a wild provenance of Pakistan,” Pak. J. Bot., vol. 39, no. 5, pp. 1443–1453, 2007.

[19] American Academy of Ophthalmology, “Conjunctivitis Preferred Practice Pattern,” San Francisco, AAO, 2023.

[20] N. Gupta and R. Agarwal, “Antibiotic resistance patterns in ocular bacterial infections,” Indian J. Ophthalmol., 2020.

[21] D. G. Hwang et al., “Comparative efficacy of ciprofloxacin and levofloxacin in ocular bacterial infections,” Cornea, 2018.

[22] A. O. Bakre et al., “Acute and subchronic toxicity of Moringa oleifera leaf extracts,” J. Ethnopharmacol., 2013.

[23] L. C. Araújo et al., “Evaluation of cytotoxic and anti-inflammatory activities of extracts and lectins from Moringa oleifera seeds,” PLoS ONE, 2013.

[24] A. K. Asiedu-Gyekye et al., “Micro- and macroelemental composition and safety evaluation of the nutraceutical Moringa oleifera leaves,” J. Toxicol., 2014.

[25] R. K. Ambi, “Physico-chemical characteristics of Moringa oleifera seeds and seed oil,” Pak. J. Bot., vol. 39, no. 5, pp. 1443–1453, 2011.

@article{1722862,
      author = {Sam-Duru Prisca Akunne, Esenwah E. C., Azuamah Y. C.; Megwas A. U., Ikoro N. C.; Daniel-Nwosu E. I., Ozurumba O. A.; Nwanesindu U. E.},
      title = {Comparative Analysis of the Effects of Moringa Oleifera Leaf Extract and Ciprofloxacin On Ocular Bacteria Infection in Owerri, Imo State},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {10},
      number = {3},
      pages = {560-563},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1722862.pdf},
      abstract = {Ocular bacterial infections are a major cause of bacteria-associated conjunctivitis and may culminate in visual impairment and blindness. The disease is treated with topical antibiotics. However, the emergence of antibiotic drug resistance in ocular infections undermines successful treatment, and alternative interventions using natural remedies are advocated. This study compared the effectiveness of Moringa oleifera leaf extract and ciprofloxacin in the treatment of ocular bacterial infections. The study was conducted at the Molecular and Biochemistry Laboratory of the Federal University of Technology, Owerri, Imo State. It adopted an experimental design involving twenty-four adult Wistar rats grouped into four groups: Group A (not infected, not treated), Group B (infected, not treated), Group C (infected and treated with Moringa oleifera leaf extract), and Group D (infected and treated with ciprofloxacin). Moringa oleifera leaf extract was prepared using the Soxhlet extraction method. Different concentrations of the extract (100 mg/ml, 75 mg/ml, 50 mg/ml) and ciprofloxacin were prepared to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against ocular bacterial isolates (Staphylococcus aureus and Streptococcus pyogenes). Data were analysed using appropriate statistical tools. The level of significance was set at P < 0.05. Moringa oleifera leaf extract contains flavonoids, saponins, alkaloids, tannins and phenols and showed antibacterial activity (P = 0.001). Quantitative analysis revealed flavonoids as the most abundant (1258.07 ± 13.30 µg/g), followed by phenols (560.47 ± 10.03 µg/g) and saponins (456.53 ± 5.62 µg/g). Tannins (20.07 ± 0.44 µg/g) and alkaloids (8.20 ± 0.35 µg/g) were present in lower amounts. At 3 mg/ml, 2 mg/ml and 1.5 mg/ml, Moringa extract produced zones of inhibition of 34.67 ± 0.57 mm, 27.33 ± 1.16 mm and 16.33 ± 0.58 mm against Streptococcus pyogenes, and 17.67 ± 2.52 mm, 18.00 ± 1.00 mm and 9.67 ± 1.53 mm against Staphylococcus aureus. Ciprofloxacin at the same concentrations produced 24.67 ± 3.51 mm, 22.67 ± 0.58 mm and 20.00 ± 1.00 mm against Streptococcus pyogenes, and 43.33 ± 3.52 mm, 32.33 ± 0.58 mm and 27.67 ± 2.52 mm against Streptococcus aureus. The findings show that Moringa oleifera leaf extract possesses significant antibacterial properties and may serve as an alternative treatment option for ocular bacterial infections. The study recommends that the leaf extract be formulated into an eye drop for the treatment of ocular bacterial infections.},
      keywords = {Moringa oleifera, Ciprofloxacin, Ocular bacterial infection, Staphylococcus aureus, Streptococcus pyogenes, Antibacterial activity.},
      month = {September},
      doi = {https://doi.org/10.64388/IREV10I3-1722862}
  }